phosphorylcholine has been researched along with Hepatocellular Carcinoma in 6 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with perifosine for 5 weeks, alone and in combination with sorafenib, strongly inhibited tumor growth and increased survival." | 5.42 | Efficacy of perifosine alone and in combination with sorafenib in an HrasG12V plus shp53 transgenic mouse model of hepatocellular carcinoma. ( Cho, KJ; Han, KH; Kim, da Y; Kim, DY; Kim, MN; Lim, HY; Park, JH; Ro, SW, 2015) |
| "Patients with liver cirrhosis of different aetiologies are at a risk to develop HCC." | 2.66 | Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma. ( Aslanidis, C; Buechler, C, 2020) |
| "Treatment with perifosine for 5 weeks, alone and in combination with sorafenib, strongly inhibited tumor growth and increased survival." | 1.42 | Efficacy of perifosine alone and in combination with sorafenib in an HrasG12V plus shp53 transgenic mouse model of hepatocellular carcinoma. ( Cho, KJ; Han, KH; Kim, da Y; Kim, DY; Kim, MN; Lim, HY; Park, JH; Ro, SW, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Buechler, C | 1 |
| Aslanidis, C | 1 |
| Kim, MN | 1 |
| Ro, SW | 1 |
| Kim, DY | 1 |
| Kim, da Y | 1 |
| Cho, KJ | 1 |
| Park, JH | 1 |
| Lim, HY | 1 |
| Han, KH | 1 |
| Miyata, R | 1 |
| Ueda, M | 2 |
| Jinno, H | 2 |
| Konno, T | 1 |
| Ishihara, K | 2 |
| Ando, N | 1 |
| Kitagawa, Y | 1 |
| Carrasco, MP | 1 |
| Jiménez-López, JM | 1 |
| Ríos-Marco, P | 1 |
| Segovia, JL | 1 |
| Marco, C | 1 |
| Cheng, ML | 1 |
| Shiao, MS | 1 |
| Chiu, DT | 1 |
| Weng, SF | 1 |
| Tang, HY | 1 |
| Ho, HY | 1 |
| Chiba, N | 1 |
| Shimada, T | 1 |
| Watanabe, J | 1 |
| Kitajima, M | 1 |
1 review available for phosphorylcholine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Role of lipids in pathophysiology, diagnosis and therapy of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cell Prolif | 2020 |
5 other studies available for phosphorylcholine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Efficacy of perifosine alone and in combination with sorafenib in an HrasG12V plus shp53 transgenic mouse model of hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma | 2015 |
Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Carcinoma, Hepatocellular; Cell | 2009 |
Disruption of cellular cholesterol transport and homeostasis as a novel mechanism of action of membrane-targeted alkylphospholipid analogues.
Topics: Antineoplastic Agents; Biological Transport; Blotting, Western; Carcinoma, Hepatocellular; Cell Line | 2010 |
Biochemical disorders associated with antiproliferative effect of dehydroepiandrosterone in hepatoma cells as revealed by LC-based metabolomics.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Proliferation; Chrom | 2011 |
Development of gene vectors for pinpoint targeting to human hepatocytes by cationically modified polymer complexes.
Topics: Adenocarcinoma; Animals; Carcinoma, Hepatocellular; Cations; Cell Line, Tumor; Female; Gene Expressi | 2007 |